Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective

Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost‐effective

Abstract High‐dose BEAM chemotherapy (BCNU, etoposide, Ara‐C, and melphalan) followed by autologous hematopoietic stem cell transplantation is frequently used as consolidative therapy for patients with recurrent or refractory Hodgkin or non‐Hodgkin lymphoma. The BEAM regimen has traditionally been a...

Full description

Bibliographic Details
Main Authors: Robin M. Reid, Andrea Baran, Jonathan W. Friedberg, Gordon L. Phillips II, Jane L. Liesveld, Michael W. Becker, Lucy Wedow, Paul M. Barr, Laurie A. Milner
Format: Article
Language:English
Published: Wiley 2016-11-01
Series:Cancer Medicine
Subjects:
Complications
conditioning chemotherapy
cost
stem cell transplantation
Online Access:https://doi.org/10.1002/cam4.879

Internet

https://doi.org/10.1002/cam4.879

Similar Items